Ibaraki, Japan

Takefumi Doi

This inventor holds 1 USPTO granted patent. Top assignee: Protein Engineering Research Institute. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takefumi Doi. Retrieved from https://idiyas.com/inventor/takefumi-doi-h7btjr0i

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takefumi Doi: Innovator in Peptide Derivatives

Introduction

Takefumi Doi is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of peptide derivatives, particularly in their application to circulatory diseases. His innovative work has led to the development of a patent that addresses critical health issues.

Latest Patents

Takefumi Doi holds a patent for peptide derivatives that exhibit binding activity to modified low-density lipoproteins (LDL). These peptide derivatives can specifically bind to modified LDL in competition with scavenger receptors on macrophages. This invention is particularly useful in diagnosing, preventing, and treating circulatory diseases caused by the accumulation of modified LDL in macrophages.

Career Highlights

Doi is affiliated with the Protein Engineering Research Institute, where he continues to advance research in peptide technology. His work has garnered attention for its potential impact on public health and medical treatments.

Collaborations

Takefumi Doi has collaborated with notable colleagues, including Toshiki Tanaka and Haruki Nakamura. Their combined expertise has contributed to the success of their research initiatives.

Conclusion

Takefumi Doi's innovative work in peptide derivatives showcases his commitment to advancing medical science. His contributions have the potential to significantly improve the diagnosis and treatment of circulatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…